Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Expert Opin Ther Targets. 2019 Apr 22;23(6):461–472. doi: 10.1080/14728222.2019.1608950

Table 2.

Selected PBC models.

Research model Background Female dominance High titer ANA/AMA Portal infiltration Bile duct dilation or proliferation References
NOD.c3c4 mice NOD mice Yes Yes Yes Yes [56, 57, 58]
dnTGFβRII mice C57BL/6J mice No Yes Yes Yes [62, 63]
Ae2a,b−/− mice FVB/NJ mice No Yes Yes Unknown [67]
ARE-Del−/− mouse C57BL/6J mice Yes Yes Yes Unknown [71, 72]
2-OA immunization Various No Yes Yes Unknown [74]
Poly I:C injection C57BL/6J mice Unknown Yes Yes Unknown [78, 79]

2-OA = 2-octynoic acid; AMA = anti-mitochondrial antibody; ANA = anti-nuclear antibody; Poly I:C = polyinosinic:polycytidylic acid